Company Profile
Hims & Hers Stock Price, News & Catalysts
- Ticker:
- HIMS
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
29.47 USD (-0.67%)
Close
Last updated: October 6, 2026
6.37B USD
Market cap
Why the stock is moving
As of Oct 6, 2026, HIMS closed down 0.67% at $29.47. No new same-company headline was identified in the current news window.
Company overview
Consumer Health and Wellness Platform
Hims & Hers provides digital access to personalized healthcare through mobile and web-based experiences. The platform connects consumers with licensed providers, treatment plans, prescription products, and ongoing support.
Broad Specialty Coverage
The company serves categories including weight management, sexual health, dermatology, hair loss, mental health, and primary-care needs. It uses common infrastructure to launch additional specialties and serve different stages of the consumer health journey.
Personalized Treatment Model
Clinical intake, provider review, diagnostics, medication selection, and follow-up are organized around individualized care plans. The platform increasingly combines multiple treatment options and behavioral support rather than offering a single standardized product.
Integrated Fulfillment Infrastructure
Hims & Hers combines telehealth with affiliated pharmacies, fulfillment centers, laboratory capabilities, and partner networks. Greater control over the care and delivery chain supports product customization and a consistent consumer experience.
Subscription and Direct-to-Consumer Distribution
Most services are acquired digitally and structured around recurring treatment relationships. Brand marketing, consumer data, and longitudinal engagement support cross-category expansion and international growth.
Future catalysts
Recent news
- 01
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hims & Hers (HIMS)?
Hims & Hers (HIMS) most recently closed at 29.47 USD, a -0.67% move versus the previous session.
What is the market cap of Hims & Hers (HIMS)?
Hims & Hers currently has a market capitalization of 6.37B USD on BioPharmSignal.
What does Hims & Hers do?
Consumer Health and Wellness Platform Hims & Hers provides digital access to personalized healthcare through mobile and web-based experiences. The platform connects consumers with licensed providers, treatment plans, prescription products, and ongoing support. Broad Specialty Coverage The company serves categories including weight management, sexual health,...
On which exchange is HIMS stock listed?
Hims & Hers (HIMS) is associated with NYSE, United States, Biopharma.
What is Consumer?
Consumer Health and Wellness Platform Hims & Hers provides digital access to personalized healthcare through mobile and web-based experiences.
Which conditions is Hims & Hers targeting with Consumer?
Hims & Hers is associated with dermatology based on its company overview and current catalyst commentary.
What is Health?
Consumer Health and Wellness Platform Hims & Hers provides digital access to personalized healthcare through mobile and web-based experiences.
What is Wellness?
Consumer Health and Wellness Platform Hims & Hers provides digital access to personalized healthcare through mobile and web-based experiences.